Clinical Report: Litigation Trends and Costs in Paediatric Urology NHS England
Overview
Analysis of NHS Resolution data from 2006 to 2025 reveals an increasing trend in paediatric urology litigation claims within NHS England, with 216 claims notified and 62% successful. The cumulative financial burden for successful claims reached over £10 million, driven primarily by failures or delays in diagnosis and treatment.
Background
Litigation in clinical care imposes significant financial and operational burdens on healthcare systems such as the NHS. Paediatric Urology, involving complex and high-risk interventions, is among specialties vulnerable to litigation. NHS Resolution manages clinical negligence claims and aims to promote learning to improve patient safety. Understanding litigation drivers and costs in paediatric urology is critical for clinicians and policymakers to enhance care quality and resource allocation.
Data Highlights
Metric
Value
Total claims (2006-2025)
216
Successful claims
134 (62%)
Cumulative damages paid
£5.32 million
NHS legal costs
£0.79 million
Claimant legal costs
£4.11 million
Average cost per successful claim
~£76,000
Increase in damages paid (2010/11 to 2024/25)
2.2-fold (£0.196M to £0.441M)
Increase in total costs (2010/11 to 2024/25)
2.4-fold (£0.412M to £0.986M)
Key Findings
Paediatric urology claims increased from 5 in 2006/07 to 18 in 2024/25, with the largest annual rise between 2016/17 and 2017/18.
Successful claims rose proportionally from fewer than 5 to 10 annually over the study period.
Failure or delay in diagnosis accounted for 29.1% of successful claims, the leading cause of litigation.
Failure or delay in treatment was the second most common cause at 24.6%.
Other notable causes included inappropriate treatment (4.4%), delay in performing operations (4.4%), and failure to organise follow-up (3.7%).
The average total cost per successful claim was approximately £76,000, including damages and legal fees.
Clinical Implications
Clinicians should prioritise timely and accurate diagnosis and treatment in paediatric urology to reduce litigation risk. Enhanced follow-up arrangements and careful procedural planning may also mitigate claims. Awareness of rising litigation costs underscores the need for systemic improvements in patient safety and risk management within paediatric urology services.
Conclusion
Litigation in paediatric urology within NHS England has increased over the past two decades, with failures in diagnosis and treatment as primary drivers. Addressing these areas may improve patient outcomes and reduce the financial burden on the NHS.
As we close out the first quarter of the twenty-first century, it isn’t hard to notice how much the world has changed since the year 2000. Smartphones. Social media. Artificial intelligence.
Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.